CORC

浏览/检索结果: 共109条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Measurement of very-high-energy diffuse gamma-ray emission from Galactic plane with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Zhang, Rui;  Zhao, Shiping;  Zhang, Yi;  Yuan, Qiang;  Cao, Zhen
收藏  |  浏览/下载:17/0  |  提交时间:2023/01/23
Observations of extended very-high-energy halos around Geminga and Monogem with the LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Guo, Yingying;  Zhang, Yi;  Yuan, Qiang;  Hu, Hongbo;  Cao, Zhen
收藏  |  浏览/下载:19/0  |  提交时间:2023/01/23
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:46/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:37/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:39/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:30/0  |  提交时间:2019/12/05
Evaluation of EPICOR Score for Predicting Two-year Outcomes in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention 会议论文
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019-04-23
作者:  Liu, Yue;  Jia, Sida;  Yao, Yi;  Tang, Xiao-Fang;  Xu, Na
收藏  |  浏览/下载:12/0  |  提交时间:2020/01/03
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Identification of States and Their Sequences in the Function Execution Process of Electromechanical Systems 会议论文
作者:  Yang, Peilin;  Xu, Kai;  Hou, Yi;  Liu, Qing;  Jia, Huanru
收藏  |  浏览/下载:4/0  |  提交时间:2019/11/19


©版权所有 ©2017 CSpace - Powered by CSpace